Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
Recall D-0264-2025, part of FDA recall event 96209. See Aspen Biopharma Labs's company page.
Aspen Biopharma Labs Pvt., Ltd. started this Class II drug recall on Feb 7, 2025 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Feb 7, 2025
- Status: Ongoing
- Products in this event: 6
CGMP Deviations
- Product
- Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
- Quantity
- 150.0 gm
- Lots and codes
- Lot Numbers: HALAC0010123, exp. date Dec-2026 HALAC0050923, exp. date Aug-2027
- Distribution
- Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
- Recalling firm
- Aspen Biopharma Labs Pvt., Ltd., Medchal Malkajgiri, India
- How the firm notified
- Letter
- FDA classified
- Mar 9, 2025
- Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover…D-0263-2025 · Class II · Feb 7, 2025 · Ongoing
- Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag…D-0262-2025 · Class II · Feb 7, 2025 · Ongoing
- Alprostadil Container Description: Amber color bottleD-0261-2025 · Class II · Feb 7, 2025 · Ongoing
- Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed…D-0260-2025 · Class II · Feb 7, 2025 · Ongoing
- Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and…D-0265-2025 · Class II · Feb 7, 2025 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports